Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Dow
Express Scripts
US Army
Chubb
QuintilesIMS
Cerilliant
Medtronic
Cipla

Generated: May 28, 2018

DrugPatentWatch Database Preview

Dutasteride; tamsulosin hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for dutasteride; tamsulosin hydrochloride and what is the scope of dutasteride; tamsulosin hydrochloride patent protection?

Dutasteride; tamsulosin hydrochloride
is the generic ingredient in two branded drugs marketed by Actavis Labs Fl Inc, Anchen Pharms, and Glaxosmithkline, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for dutasteride; tamsulosin hydrochloride. Five suppliers are listed for this compound.
Pharmacology for dutasteride; tamsulosin hydrochloride

US Patents and Regulatory Information for dutasteride; tamsulosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anchen Pharms DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 202509-001 Feb 26, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline JALYN dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 022460-001 Jun 14, 2010 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 202975-001 Nov 20, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for dutasteride; tamsulosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline JALYN dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 022460-001 Jun 14, 2010 ➤ Sign Up ➤ Sign Up
Glaxosmithkline JALYN dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 022460-001 Jun 14, 2010 ➤ Sign Up ➤ Sign Up
Glaxosmithkline JALYN dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 022460-001 Jun 14, 2010 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Teva
UBS
Dow
Mallinckrodt
Queensland Health
Baxter
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.